Online citations, reference lists, and bibliographies.
← Back to Search

The Impact Of Nanobiotechnology On The Development Of New Drug Delivery Systems.

O. Kayser, A. Lemke, N. Hernández-Trejo
Published 2005 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology, or systems/devices manufactured at the molecular level, is a multidisciplinary scientific field undergoing explosive development. A part of this field is the development of nanoscaled drug delivery devices. Nanoparticles have been developed as an important strategy to deliver conventional drugs, recombinant proteins, vaccines and more recently nucleotides. Nanoparticles and other colloidal drug delivery systems modify the kinetics, body distribution and drug release of an associated drug. Other effects are tissue or cell specific targeting of drugs and the reduction of unwanted side effects by a controlled release. Therefore nanoparticles in the pharmaceutical biotechnology sector improve the therapeutic index and provide solutions for future delivery problems for new classes of so called biotech drugs including recombinant proteins and oligonucleotides. This review discusses nanoparticular drug carrier systems with the exception of liposomes used today, and what the potential and limitations of nanoparticles in the field of pharmaceutical biotechnology are.
This paper references



This paper is referenced by
10.2217/17435889.3.3.367
Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.
F. Chiellini (2008)
10.18535/ijmsci/v2i12.01
PLGA Based Nanoencapsulation For Controlled Release Of Doxorubicin For Cancer Therapy
P. Sasikumar (2015)
NANOTECHNOLOGY: A NEW APPROACH FOR OCULAR DRUG DELIVERY SYSTEM
Meetali Mudgil (2012)
Immunological Evaluation of Biodegradable Particle Based Nanoparticles Encapsulating OMP Antigen as Potential Vaccine Candidate
P. R. Rauta (2016)
10.1007/978-0-387-77668-2_20
Nanotechnology in Drug Development and Life Cycle Management
Shingai Majuru (2009)
10.1002/9781118229347.CH5
Nanotechnology‐Enabled Delivery Systems for Food Functionalization and Fortification
Rashmi Tiwari (2012)
10.17756/NWJ.2017-049
In Vitro Anticancer Activity of Green Synthesis Ruthenium Nanoparticle from Dictyota dichotoma Marine Algae
Mohamed Yacoob Syed Ali (2017)
10.1201/9781315114361-4
Chapter 3: Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics and Imaging
S. Parveen (2017)
10.1504/IJNT.2006.011179
Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
K. Subramani (2006)
NANOTECHNOLOGY OF ANTICANCER DRUGS IN NOVEL DRUG DELIVERY SYSTEM - AN OVERVIEW
M. Senthilkumar (2011)
10.1007/978-1-59745-218-2_13
Nano-Sized Carriers for Drug Delivery
S. Sahoo (2008)
10.1016/J.MSPRO.2015.11.128
Carbon Nanotubes for Delivery of Quercetin as Anticancer Drug: Theoretical Study
Shahla Daneshmehr (2015)
10.1007/978-3-662-56333-5_8
MRI and Ultrasound Imaging of Nanoparticles for Medical Diagnosis
Or Perlman (2018)
10.4103/0259-1162.118976
Current status of nanomedicine and nanosurgery
S. Singh (2013)
10.13130/ARRIGONI-ELENA_PHD2012-02-03
ADIPOSE-DERIVED STEM CELLS (ASCS) FOR FUTURE CELLULAR THERAPIES IN MUSCLE-SKELETAL TISSUES REGENERATION
E. Arrigoni (2012)
POLYMERS FOR DRUG DELIVERY SYSTEM : A REVIEW
S. Yogesh (2010)
10.1016/B978-0-12-416020-0.00014-0
Cell delivery of therapeutic nanoparticles.
J. McMillan (2011)
10.1201/B13159-3
Nanomedicines Impacts in Ocular Delivery and Targeting
Y. Omidi (2012)
Nanosuspensions: A Versatile Formulation Technique for Drugs with Poor Aqueous Solubility- A Review
Sharwan Kumar Dewan (2013)
Nanocapsules Used in Drug Delivery System
Praveen Solanki (2017)
Development of colloids for cell and tissue targeting: bisphosphonate-functionalized gold nanoparticles for the investigation of bone targeting
G. Zayed (2010)
10.5681/bi.2011.003
Impacts of nanomedicines in ocular pharmacotherapy.
A. Nakhlband (2011)
10.3390/v4040488
Nanotechnology and the Treatment of HIV Infection
R. Parboosing (2012)
10.1016/J.MATLET.2014.05.110
Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: A potential in situ therapeutic device
S. Simović (2014)
10.1007/978-3-319-41129-3_2
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
10.1016/J.MICROMESO.2016.11.004
Study on release of naproxen and metformin encapsulated in biopolymer-inorganic mesoporous matrices as controlled drug-delivery systems
Marieh Ghazaie (2017)
10.1007/12_2012_198
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
S. K. Pandey (2013)
10.1517/17425247.2011.604311
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
H. Harde (2011)
10.5772/33521
Cytotoxicity of Tamoxifen-Loaded Solid Lipid Nanoparticles
Roghayeh Abbasalipourkabir (2012)
Nanotecnologie: una grande rivoluzione che parte dal piccolo
Matteo Bassi (2013)
10.1016/j.drudis.2007.10.021
Nanotechnology in ocular drug delivery.
S. Sahoo (2008)
10.1007/978-3-642-29265-1_9
Nanotechnology in Ophthalmic Drug Delivery
Ali A Al-Kinani (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar